Acquired Digital Fibrokeratoma 

  • Author: Elizabeth Kline Satter, MD, MPH; Chief Editor: William D James, MD   more...
 
Updated: Jul 11, 2011
 

Background

In 1968, Bart et al[1] described 10 cases of an uncommon acquired growth that was located on the fingers. Although it clinically resembled a cutaneous horn or rudimentary supernumerary digit, it had distinct histopathological findings. The authors named this growth acquired digital fibrokeratoma (ADFK). Subsequently, Pinkus[2] reported 28 more cases; however, these lesions occurred not only on the fingers, but also on the proximal hand, toes, sole, and one in the prepatellar region. For this reason, Verallo et al suggested the entity might more appropriately be called an acral fibrokeratoma.[3]

Similar growths have been reported to occur in the subungual or periungual region of patients with tuberous sclerosis, and they are referred to as Koenen tumors or garlic clove fibromas. They differ, however, in that they tend to be multilobulated and involve several digits and, histologically, may have atypical stellate myofibroblasts.[4]

Next

Pathophysiology

Despite the fact that most patients deny a history of precedent trauma, the major hypothesis is that subclinical injury contributes to the development of acquired digital fibrokeratomas. One case report describes an ADFK on the toe developing simultaneously with gingival overgrowth in a renal transplantation patient on cyclosporine, which the authors suggested may represent a causal association.[5]

Previous
Next

Epidemiology

Frequency

United States

Currently, no means of tracking nonmelanoma skin cancer, much less various benign dermatological conditions, are available in the United States; therefore, the actual incidence of acquired acral fibrokeratoma is unknown. Most cases of acquired digital fibrokeratoma reported in the literature involve individual case reports presented because of the lesions' unusual size, location, histological features, or association with other conditions. Only a few reports of describe a series of patients, with 50 patients being the most reported from any one institution.[6] Therefore, whether acquired digital fibrokeratoma is rare or rarely reported remains unclear.

Mortality/Morbidity

Acquired digital fibrokeratomas are benign stationary lesions that are more cosmetically bothersome than they are problematic. However, patients who have been reported to have giant acral digital fibromas on the dorsum or plantar surface[7, 8, 9] of the foot may report some discomfort.[8]

Race

Acquired digital fibrokeratomas have been reported in persons of all races.

Sex

Acquired digital fibrokeratomas seem to have a slight male predominance; however, at this time too few cases have been described to adequately assess the significance of any sexual predilection.[10]

Age

The patients reported with acquired digital fibrokeratomas range in age from 12-70 years, with most cases occurring in middle-aged adults. Clinically similar lesions that occur in young children are more likely to represent rudimentary supernumerary digits.

Previous
 
 
Contributor Information and Disclosures
Author

Elizabeth Kline Satter, MD, MPH  Chairman, Department of Dermatology, Naval Medical Center San Diego

Elizabeth Kline Satter, MD, MPH is a member of the following medical societies: Alpha Omega Alpha and American Medical Women's Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Abby S Van Voorhees, MD  Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania

Abby S Van Voorhees, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, National Psoriasis Foundation, Phi Beta Kappa, Sigma Xi, and Women's Dermatologic Society

Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Merck Salary Management position; Abbott Honoraria Speaking and teaching; Amgen Honoraria Review panel membership; Centocor Honoraria Consulting; Leo Consulting; Merck None Other

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Christen M Mowad, MD  Associate Professor, Department of Dermatology, Geisinger Medical Center

Christen M Mowad, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Joel M Gelfand, MD, MSCE  Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania

Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology

Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds Investigator; Genentech Grant/research funds investigator; Centocor Consulting fee Consulting; Abbott Grant/research funds investigator; Abbott Consulting fee Consulting; Novartis investigator; Pfizer Grant/research funds investigator; Celgene Consulting fee DMC Chair; NIAMS and NHLBI Grant/research funds investigator

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

References
  1. Bart RS, Andrade R, Kopf AW, Leider M. Acquired digital fibrokeratomas. Arch Dermatol. Feb 1968;97(2):120-9. [Medline].

  2. Pinkus H. Discussion - Acquired digital fibrokeratoma. Arch Dermatol. 1968;97:128-9.

  3. Verallo VV. Acquired digital fibrokeratomas. Br J Dermatol. Nov 1968;80(11):730-6. [Medline].

  4. Carlson RM, Lloyd KM, Campbell TE. Acquired periungual fibrokeratoma: a case report. Cutis. Aug 2007;80(2):137-40. [Medline].

  5. Qiao J, Liu YH, Fang K. Acquired digital fibrokeratoma associated with ciclosporin treatment. Clin Exp Dermatol. Mar 2009;34(2):257-9. [Medline].

  6. Kint A, Baran R. Histopathologic study of Koenen tumors. Are they different from acquired digital fibrokeratoma?. J Am Acad Dermatol. Feb 1988;18(2 Pt 1):369-72. [Medline].

  7. Bron C, Noel B, Panizzon RG. Giant fibrokeratoma of the heel. Dermatology. 2004;208(3):271-2. [Medline].

  8. Spitalny AD, Lavery LA. Acquired fibrokeratoma of the heel. J Foot Surg. Sep-Oct 1992;31(5):509-11. [Medline].

  9. de Freitas PM, de Sb Xavier MH, Pereira GB, et al. Acquired fibrokeratoma presenting as a giant pedunculated lesion on the heel. Dermatol Online J. Dec 15 2008;14(12):10. [Medline].

  10. Baykal C, Buyukbabani N, Yazganoglu KD, Saglik E. Acquired digital fibrokeratoma. Cutis. Feb 2007;79(2):129-32. [Medline].

  11. Kakurai M, Yamada T, Kiyosawa T, Ohtsuki M, Nakagawa H. Giant acquired digital fibrokeratoma. J Am Acad Dermatol. May 2003;48(5 Suppl):S67-8. [Medline].

  12. Vinson RP, Angeloni VL. Acquired digital fibrokeratoma. Am Fam Physician. Oct 1995;52(5):1365-7. [Medline].

  13. Moulin G, Balme B, Thomas L. Familial multiple acral mucinous fibrokeratomas. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):999-1001. [Medline].

  14. Dominguez-Cherit J, Garcia C, Vega-Memije ME, Arenas R. Pseudo-fibrokeratoma: an unusual presentation of subungual squamous cell carcinoma in a young girl. Dermatol Surg. Jul 2003;29(7):788-9. [Medline].

  15. Chi CC, Kuo TT, Wang SH. Aggressive digital papillary adenocarcinoma: a silent malignancy masquerading as acquired digital fibrokeratoma. Am J Clin Dermatol. 2007;8(4):243-5. [Medline].

  16. Kint A, Baran R, De Keyser H. Acquired (digital) fibrokeratoma. J Am Acad Dermatol. May 1985;12(5 Pt 1):816-21. [Medline].

  17. Nickel WR, Reed WB. Tuberous sclerosis. Special reference to the microscopic alterations in the cutaneous hamartomas. Arch Dermatol. Feb 1962;85:209-26. [Medline].

  18. Hare PJ, Smith PA. Acquired (digital) fibrokeratoma. Br J Dermatol. Sep 1969;81(9):667-70. [Medline].

  19. Hemric JR, Allen HB. Acquired digital fibrokeratoma. Cutis. Mar 1979;23(3):304-6. [Medline].

  20. Jaiswal AK, Chatterjee M. Acquired (digital) fibrokeratoma. Indian J Dermatol Venereol Leprol. May-Jun 2002;68(3):179-80. [Medline].

  21. Kumari R, Thappa DM, Devi A. Periunungal acquired digital fibrokeratoma. Indian J Dermatol Venereol Leprol. 2009;75:72.

  22. Saito S, Ishikawa K. Acquired periungual fibrokeratoma with accessory germinal matrix. J Hand Surg [Br]. Dec 2002;27(6):549-55. [Medline].

Previous
Next
 
Clinical picture of a pedunculated acquire digital fibrokeratoma.
Flat-topped, skin-colored acquired digital fibrokeratoma in an acral location.
Slightly raised skin encircling the base of an acquired digital fibrokeratoma, creating a moat.
Domed-shaped papule with overlying hyperkeratosis. The dermal core is composed of increased collagen bundles and blood vessels oriented along the vertical axis of the lesion.
Close up showing the increased collagen bundles and blood vessels oriented along the vertical axis of the lesion.
A different acquired digital fibrokeratoma showing similar findings of a domed-shaped lesion with a vertically aligned fibrovascular core.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.